Phase II Trial of Gliadel® plus O(6)-Benzylguanine (O(6)-BG) in Adults with Recurrent Glioblastoma Multiforme

PURPOSE: This phase II trial was designed to: define the efficacy of Gliadel® wafers in combination with an infusion of O(6)-BG that suppresses tumor O(6)-alkylguanine-DNA alkyltransferase (AGT) levels in patients with recurrent GBM for 5 days; and evaluate the safety of this combination therapy. PA...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Quinn, Jennifer A., Jiang, Sara Xiaoyin, Carter, James, Reardon, David A., Desjardins, Annick, Vredenburgh, James J., Rich, Jeremy N., Gururangan, Sridharan, Friedman, Allan H., Bigner, Darell D., Sampson, John H., McLendon, Roger E., Herndon, James E., Threatt, Stevie, Friedman, Henry S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2009
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2710963/
https://ncbi.nlm.nih.gov/pubmed/19188181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-2130
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia